The Challenges of Interstitial Cystitis: Current Status and Future Prospects Samuel BelknapEric BlalockDeborah Erickson Current Opinion 24 November 2015 Pages: 2057 - 2063
Disease-Modifying Drugs in Parkinson’s Disease Ariane ParkMark Stacy Leading Article 18 November 2015 Pages: 2065 - 2071
Lipoglycopeptide Antibacterial Agents in Gram-Positive Infections: A Comparative Review Françoise Van Bambeke Review Article 24 November 2015 Pages: 2073 - 2095
Complicated Intra-Abdominal Infections: The Old Antimicrobials and the New Players Young R. LeeDanni McMahanGregory K. Perry Review Article 26 November 2015 Pages: 2097 - 2117
Adalimumab: A Review in Chronic Plaque Psoriasis Celeste B. BurnessKate McKeage Adis Drug Evaluation 19 November 2015 Pages: 2119 - 2130
Netupitant/Palonosetron: A Review in the Prevention of Chemotherapy-Induced Nausea and Vomiting Gillian M. Keating Adis Drug Evaluation 27 November 2015 Pages: 2131 - 2141
Lacosamide: A Review in Focal Seizures in Patients with Epilepsy Lesley J. Scott Adis Drug Evaluation 25 November 2015 Pages: 2143 - 2154
Idarucizumab: First Global Approval Celeste B. Burness AdisInsight Report 17 November 2015 Pages: 2155 - 2161
Mepolizumab: First Global Approval Gillian M. Keating AdisInsight Report 24 November 2015 Pages: 2163 - 2169
Erratum to: Pharmacologic Targeting of Regulatory T Cells for Solid Organ Transplantation: Current and Future Prospects Kassem SafaSindhu ChandranDavid Wojciechowski Erratum 09 November 2015 Pages: 2171 - 2171
